Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Observational × belzutifan × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

von Hippel-Lindau Disease 1

Interventions

Blood Specimen Collection 12 Surveys and Questionnaires 10 Psychiatric Rehabilitation 7 Therapeutics 6 Polymerase Chain Reaction 5 Interviews as Topic 5 Immunohistochemistry 5 Gene Expression Profiling 5 Biopsy 5 Radiotherapy 4 Reverse Transcriptase Polymerase Chain Reaction 3 Microarray Analysis 3 Magnetic Resonance Spectroscopy 3 High-Energy Shock Waves 3 Abiraterone Acetate 3 Watchful Waiting 2 Standard of Care 2 Specimen Handling 2 Prednisone 2 Leuprolide 2 In Situ Hybridization, Fluorescence 2 Hematologic Tests 2 Glucose Tolerance Test 2 Fluorodeoxyglucose F18 2 Drug Therapy 2 Comparative Genomic Hybridization 2 Chemotherapy, Adjuvant 2 Bariatric Surgery 2 Azacitidine 2 Amplified Fragment Length Polymorphism Analysis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06554730 2024-11-29

MK-6482-026

Merck Sharp & Dohme LLC

von Hippel-Lindau Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡